Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-29

Clinical Trial Update: The Antidepressant Efficacy of Low Frequency rTMS as add-on [NA]

View source ↗

Summary

The clinical trial evaluating low-frequency rTMS as an add-on treatment for depression has been withdrawn from clinicaltrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low-frequency repetitive transcranial magnetic stimulation (rTMS) add-on therapy

Snippet

Sponsor: University of Aarhus | Conditions: Depression | NA | Status: WITHDRAWN